Jeffrey J. Raizer

机构：Northwestern University, Amyotrophic Lateral Sclerosis Therapy Development Institute, Northwestern University, Takeda (United States), Northwestern Medicine · ORCID：0009-0003-8469-2509

发表论文 353 篇 · 总被引 13477 次 · h-index 54

代表论文

• Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma (2024 · Neuro-Oncology Advances · 被引 10)
• A Phase II Trial of Bevacizumab in Patients with Recurrent/Progressive Solid Tumor Brain Metastases That Have Progressed Following Whole-Brain Radiation Therapy (2024 · Cancers · 被引 6)
• Phase 1b Study of Dazostinag plus Pembrolizumab after Hypofractionated Radiotherapy in Patients with Select Advanced Solid Tumors (2025 · Cancer Research Communications · 被引 5)
• Reversible downregulation of HLA class I in adenoid cystic carcinoma (2025 · Journal for ImmunoTherapy of Cancer · 被引 5)
• 996MO Dazostinag (TAK-676) alone and in combination with pembrolizumab (pembro) in patients (pts) with advanced/metastatic solid tumors: Data from phase I dose escalation (2024 · Annals of Oncology · 被引 5)
• Abstract 7143: Development of a peripheral dazostinag (TAK-676) activation RNASeq signature to evaluate STING pharmacodynamic modulation in human solid tumor clinical trials (2025 · Cancer Research · 被引 2)